INS and Hypoglycemia: In conclusion, this study demonstrated that once-weekly insulin achieved superior HbA1c control compared to once-daily insulin, with no significant differences in clinically significant or severe hypoglycemic events, although the risk of weight gain and level 1 hypoglycemia events was slightly increased.